Pharmacokinetics
479
20
24
371
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
79 trials with published results (16%)
Research Maturity
371 completed trials (77% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
9 terminated out of 479 trials
97.6%
+11.1% vs benchmark
7%
33 trials in Phase 3/4
21%
79 of 371 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 371 completed trials
Clinical Trials (479)
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
PK/PD of Caspofungin in Children Severe Infection
A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose
Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule
Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Antibiotic Dosing in Pediatric Intensive Care
A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants
Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
Study of BB-025, Alone and After BB-031, in Healthy Volunteers
Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.